| Entry |
|
|---|
| Name |
Volociximab (USAN)
|
|---|
| Formula |
C6434H9942N1706O2040S52
|
|---|
| Exact mass |
145409.2142
|
|---|
| Mol weight |
145499.3695
|
|---|
| Activity |
Antiangiogenic agent to treat solid tumors and age-related macular degeneration
|
|---|
| Comment |
chimeric monoclonal antibody
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Others
Cell adhesion molecules (CAMs)
integrin alpha5/beta1 (VLA-5) [HSA:3678 3688] [KO:K06484 K05719]
Volociximab
D06319 Volociximab (USAN)
 |
|---|
| Other DBs |
|
|---|
